Apellis Pharmaceuticals Inc.

(NASDAQ:APLS) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade.

Contact Information

Website: www.apellis.com
Email: investors@apellis.com
Main Phone: +1 617 977-5700
Address: 100 Fifth Avenue
Address 2: Suite A
State: MA
City / Town: Waltham
Country: US
Postal Code: 02451

Issuer Information

Exchange: NGS
CEO: Cedric Francois
Employees: 374
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A